Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobal, S. L.
Right arrow Articles by Siegel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobal, S. L.
Right arrow Articles by Siegel, R. J.
(Chest. 2004;125:293-296.)
© 2004 American College of Chest Physicians

Making an Impossible Mission Possible*

Sergio L. Kobal, MD; Lawrence S. C. Czer, MD; Peter C. Czer; Zhanna Feldsher, MD; Robert Hamilton, MD and Robert J. Siegel, MD

* From the Cardiology Division, Cedars-Sinai Medical Center, and School of Medicine, University of California, Los Angeles, CA.

Correspondence to: Robert J. Siegel, MD, Cardiac Non-Invasive Laboratory, Room #5335, Cedars-Sinai Medical Center, Los Angeles, CA 90048; e-mail: siegel{at}cshs.org

Cardiovascular disease (CVD) is widespread in developing countries. Hypertension is a major contributor of CVD. Left ventricular hypertrophy (LVH) is a risk marker in hypertensive populations. Identification of LVH and treatment of high-risk patients can result in more effective use of the limited resources. LVH is diagnosed by echocardiography, often unavailable in developing countries. In Gambia, we used a hand-carried ultrasound (HCU) to examine 1,997 people. Seventeen percent had hypertension; of these, LVH was found in 65%. The battery-powered HCU permits clinicians to detect LVH in areas with limited access to diagnostic equipment, allowing identification of a high-risk hypertensive population.

Key Words: cardiovascular disease • developing countries • hand-carried cardiac ultrasound • hypertension • risk stratification




This article has been cited by other articles:


Home page
 BMJHome page
S Kadiri
Tackling cardiovascular disease in Africa
BMJ, October 1, 2005; 331(7519): 711 - 712.
[Full Text] [PDF]

Home page
 ChestHome page
S. L. Kobal, S. Atar, and R. J. Siegel
Hand-Carried Ultrasound Improves the Bedside Cardiovascular Examination
Chest, September 1, 2004; 126(3): 693 - 701.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.